Symbols / SHC Stock $15.33 -1.92% Sotera Health Company
SHC (Stock) Chart
About
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.
Stock Fundamentals
Scroll to Statements| Market Cap | 4.37B | Enterprise Value | 6.29B | Income | 77.94M | Sales | 1.16B | Book/sh | 2.13 | Cash/sh | 1.21 |
| Dividend Yield | — | Payout | 0.00% | Employees | 3000 | IPO | — | P/E | 56.78 | Forward P/E | 14.65 |
| PEG | 1.31 | P/S | 3.76 | P/B | 7.19 | P/C | — | EV/EBITDA | 11.37 | EV/Sales | 5.41 |
| Quick Ratio | 2.09 | Current Ratio | 2.46 | Debt/Eq | 375.56 | LT Debt/Eq | — | EPS (ttm) | 0.27 | EPS next Y | 1.05 |
| EPS Growth | 175.40% | Revenue Growth | 4.60% | Earnings | 2026-05-05 | ROA | 8.18% | ROE | 15.42% | ROIC | — |
| Gross Margin | 55.48% | Oper. Margin | 35.75% | Profit Margin | 6.70% | Shs Outstand | 285.16M | Shs Float | 191.73M | Short Float | 4.90% |
| Short Ratio | 3.31 | Short Interest | — | 52W High | 19.85 | 52W Low | 10.68 | Beta | 1.88 | Avg Volume | 2.62M |
| Volume | 1.92M | Target Price | $20.50 | Recom | Buy | Prev Close | $15.63 | Price | $15.33 | Change | -1.92% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-14 | main | Barclays | Overweight → Overweight | $18 |
| 2026-02-24 | main | Citigroup | Buy → Buy | $23 |
| 2026-01-09 | up | Piper Sandler | Neutral → Overweight | $24 |
| 2025-12-18 | init | William Blair | — → Outperform | — |
| 2025-11-13 | init | BMO Capital | — → Outperform | $19 |
| 2025-11-05 | main | JP Morgan | Neutral → Neutral | $16 |
| 2025-11-05 | main | Barclays | Overweight → Overweight | $20 |
| 2025-11-05 | main | Piper Sandler | Neutral → Neutral | $17 |
| 2025-10-02 | main | Barclays | Overweight → Overweight | $19 |
| 2025-06-24 | main | Barclays | Overweight → Overweight | $13 |
| 2025-05-05 | up | Goldman Sachs | Neutral → Buy | $17 |
| 2025-04-23 | main | Piper Sandler | Neutral → Neutral | $13 |
| 2025-04-10 | main | Barclays | Overweight → Overweight | $12 |
| 2025-02-28 | main | Barclays | Overweight → Overweight | $16 |
| 2025-02-18 | main | Barclays | Overweight → Overweight | $17 |
| 2024-11-21 | reit | RBC Capital | Outperform → Outperform | $17 |
| 2024-11-06 | main | Citigroup | Buy → Buy | $20 |
| 2024-08-06 | main | Barclays | Overweight → Overweight | $17 |
| 2024-08-06 | reit | RBC Capital | Outperform → Outperform | $17 |
| 2024-05-21 | init | Piper Sandler | — → Neutral | $13 |
News
RSS: Latest SHC news- All you need to know about Sotera Health (SHC) rating upgrade to buy - MSN hu, 23 Apr 2026 20
- Before markets open May 5, Sotera Health will post Q1 results - Stock Titan ue, 21 Apr 2026 11
- (SHC) Movement as an Input in Quant Signal Sets - Stock Traders Daily hu, 23 Apr 2026 15
- Sotera Health Company to Release First-Quarter Financial Results on May 5, 2026 - Quiver Quantitative ue, 21 Apr 2026 12
- Sotera Health Co (SHC) Stock Price Today & Analysis - Gotrade ue, 13 Jan 2026 00
- Shaftesbury Capital (LON:SHC) Stock Price Up 0.2% - Should You Buy? - MarketBeat Fri, 10 Apr 2026 07
- Sotera Health (SHC) Soars 8.2%: Is Further Upside Left in the Stock? - Yahoo Finance Wed, 01 Apr 2026 07
- Sotera Health Company (SHC): Buy, Sell, or Hold Post Q4 Earnings? - StockStory ue, 07 Apr 2026 07
- Sotera Health Company (SHC) Stock Analysis: A 9.94% Potential Upside with Robust Revenue Growth - DirectorsTalk Interviews ue, 27 Jan 2026 08
- SHC Stock Analysis: Sotera Health Company gains 0.61 percent near 15 dollar mark - UBND thành phố Hải Phòng Fri, 03 Apr 2026 07
- Why Sotera Health Company (SHC) Stock Is Trading Lower Today - Yahoo Finance hu, 04 Sep 2025 07
- $SHC ($SHC) Releases Q4 2025 Earnings - Quiver Quantitative ue, 24 Feb 2026 08
- Erika Ostrowski (SHC) details stock and RSU holdings in Form 3 - Stock Titan Wed, 08 Apr 2026 07
- Sotera Health (SHC) records RSU tax-withholding for ex-SVP Dimitrief - Stock Titan hu, 02 Apr 2026 07
- With 48% ownership, Sotera Health Company (NASDAQ:SHC) has piqued the interest of institutional investors - Yahoo Finance Fri, 19 Dec 2025 08
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
1,163.62
+5.74%
|
1,100.44
+4.88%
|
1,049.29
+4.54%
|
1,003.69
|
| Operating Revenue |
|
1,163.62
+5.74%
|
1,100.44
+4.88%
|
1,049.29
+4.54%
|
1,003.69
|
| Cost Of Revenue |
|
518.08
+4.00%
|
498.15
+5.51%
|
472.13
+5.70%
|
446.68
|
| Reconciled Cost Of Revenue |
|
412.12
+3.93%
|
396.55
+4.91%
|
378.00
+3.83%
|
364.07
|
| Gross Profit |
|
645.53
+7.18%
|
602.29
+4.36%
|
577.16
+3.62%
|
557.00
|
| Operating Expense |
|
283.50
-6.95%
|
304.67
+1.40%
|
300.47
-2.65%
|
308.65
|
| Selling General And Administration |
|
252.76
+4.18%
|
242.63
+2.52%
|
236.67
-3.68%
|
245.71
|
| Total Expenses |
|
801.58
-0.15%
|
802.82
+3.91%
|
772.60
+2.28%
|
755.34
|
| Operating Income |
|
362.03
+21.64%
|
297.63
+7.57%
|
276.69
+11.41%
|
248.35
|
| Total Operating Income As Reported |
|
—
|
297.63
+7.57%
|
276.69
+11.41%
|
248.35
|
| EBITDA |
|
439.93
-0.51%
|
442.20
+8.69%
|
406.83
+2436.36%
|
-17.41
|
| Normalized EBITDA |
|
507.29
+8.73%
|
466.57
+5.56%
|
441.99
+10.40%
|
400.35
|
| Reconciled Depreciation |
|
136.71
-16.46%
|
163.64
+3.62%
|
157.93
+8.50%
|
145.55
|
| EBIT |
|
303.23
+8.85%
|
278.56
+11.92%
|
248.91
+252.73%
|
-162.97
|
| Total Unusual Items |
|
-67.35
-176.41%
|
-24.37
+30.69%
|
-35.16
+91.58%
|
-417.76
|
| Total Unusual Items Excluding Goodwill |
|
-67.35
-176.41%
|
-24.37
+30.69%
|
-35.16
+91.58%
|
-417.76
|
| Special Income Charges |
|
-66.41
-174.76%
|
-24.17
+30.95%
|
-35.00
+91.62%
|
-417.61
|
| Other Special Charges |
|
66.41
+174.76%
|
24.17
-30.95%
|
35.00
-91.42%
|
408.00
|
| Impairment Of Capital Assets |
|
—
|
—
|
—
|
—
|
| Write Off |
|
—
|
0.00
|
0.00
-100.00%
|
9.61
|
| Net Income |
|
77.95
+75.57%
|
44.40
-13.58%
|
51.38
+122.00%
|
-233.57
|
| Pretax Income |
|
147.51
+29.53%
|
113.87
+7.40%
|
106.03
+143.61%
|
-243.11
|
| Net Non Operating Interest Income Expense |
|
-155.72
+5.45%
|
-164.69
-15.27%
|
-142.88
-78.28%
|
-80.14
|
| Interest Expense Non Operating |
|
155.72
-5.45%
|
164.69
+15.27%
|
142.88
+78.28%
|
80.14
|
| Net Interest Income |
|
-155.72
+5.45%
|
-164.69
-15.27%
|
-142.88
-78.28%
|
-80.14
|
| Interest Expense |
|
155.72
-5.45%
|
164.69
+15.27%
|
142.88
+78.28%
|
80.14
|
| Other Income Expense |
|
-58.81
-208.51%
|
-19.06
+31.40%
|
-27.79
+93.24%
|
-411.32
|
| Other Non Operating Income Expenses |
|
8.55
+61.06%
|
5.31
-28.02%
|
7.37
+14.45%
|
6.44
|
| Gain On Sale Of Security |
|
-0.95
-375.88%
|
-0.20
-25.16%
|
-0.16
-9.66%
|
-0.14
|
| Tax Provision |
|
69.56
+0.12%
|
69.48
+27.13%
|
54.65
+672.80%
|
-9.54
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+435.10%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-14.14
-176.41%
|
-5.12
+30.69%
|
-7.38
+54.97%
|
-16.40
|
| Net Income Including Noncontrolling Interests |
|
77.95
+75.57%
|
44.40
-13.58%
|
51.38
+122.00%
|
-233.57
|
| Net Income From Continuing Operation Net Minority Interest |
|
77.95
+75.57%
|
44.40
-13.58%
|
51.38
+122.00%
|
-233.57
|
| Net Income From Continuing And Discontinued Operation |
|
77.95
+75.57%
|
44.40
-13.58%
|
51.38
+122.00%
|
-233.57
|
| Net Income Continuous Operations |
|
77.95
+75.57%
|
44.40
-13.58%
|
51.38
+122.00%
|
-233.57
|
| Minority Interests |
|
—
|
—
|
0.00
|
0.00
|
| Normalized Income |
|
131.16
+106.07%
|
63.65
-19.59%
|
79.15
-52.83%
|
167.79
|
| Net Income Common Stockholders |
|
77.95
+75.57%
|
44.40
-13.58%
|
51.38
+122.00%
|
-233.57
|
| Diluted EPS |
|
0.27
+68.75%
|
0.16
-11.11%
|
0.18
+121.69%
|
-0.83
|
| Basic EPS |
|
0.27
+68.75%
|
0.16
-11.11%
|
0.18
+121.69%
|
-0.83
|
| Basic Average Shares |
|
283.96
+0.41%
|
282.78
+0.63%
|
281.01
+0.33%
|
280.10
|
| Diluted Average Shares |
|
286.42
+0.53%
|
284.91
+0.59%
|
283.22
+1.12%
|
280.10
|
| Diluted NI Availto Com Stockholders |
|
77.95
+75.57%
|
44.40
-13.58%
|
51.38
+122.00%
|
-233.57
|
| Amortization |
|
30.74
-50.45%
|
62.04
-2.76%
|
63.80
+1.36%
|
62.94
|
| Amortization Of Intangibles Income Statement |
|
30.74
-50.45%
|
62.04
-2.76%
|
63.80
+1.36%
|
62.94
|
| Depreciation Amortization Depletion Income Statement |
|
30.74
-50.45%
|
62.04
-2.76%
|
63.80
+1.36%
|
62.94
|
| Depreciation And Amortization In Income Statement |
|
30.74
-50.45%
|
62.04
-2.76%
|
63.80
+1.36%
|
62.94
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
3,263.19
+6.24%
|
3,071.65
-1.88%
|
3,130.42
+0.41%
|
3,117.70
|
| Current Assets |
|
613.41
+16.61%
|
526.04
-5.60%
|
557.24
-13.61%
|
645.01
|
| Cash Cash Equivalents And Short Term Investments |
|
344.62
+24.30%
|
277.24
-6.47%
|
296.41
-25.00%
|
395.21
|
| Cash And Cash Equivalents |
|
344.62
+24.30%
|
277.24
-6.47%
|
296.41
-25.00%
|
395.21
|
| Receivables |
|
176.27
+6.31%
|
165.81
-5.53%
|
175.52
+12.72%
|
155.72
|
| Accounts Receivable |
|
139.33
-0.71%
|
140.33
-4.99%
|
147.70
+24.66%
|
118.48
|
| Gross Accounts Receivable |
|
142.30
-0.39%
|
142.86
-6.25%
|
152.38
+26.62%
|
120.35
|
| Allowance For Doubtful Accounts Receivable |
|
-2.97
-17.22%
|
-2.53
+46.00%
|
-4.69
-150.61%
|
-1.87
|
| Other Receivables |
|
24.41
+60.45%
|
15.21
-14.46%
|
17.79
-24.32%
|
23.50
|
| Taxes Receivable |
|
12.53
+21.98%
|
10.27
+2.31%
|
10.04
-26.91%
|
13.73
|
| Inventory |
|
54.38
+10.61%
|
49.16
+1.74%
|
48.32
+30.07%
|
37.15
|
| Raw Materials |
|
45.57
+7.45%
|
42.41
-2.31%
|
43.41
+19.25%
|
36.40
|
| Work In Process |
|
2.44
+162.22%
|
0.93
+97.24%
|
0.47
-19.35%
|
0.58
|
| Finished Goods |
|
6.62
+9.65%
|
6.04
+29.31%
|
4.67
+1592.03%
|
0.28
|
| Prepaid Assets |
|
17.09
-0.92%
|
17.24
+7.15%
|
16.09
-60.14%
|
40.38
|
| Restricted Cash |
|
1.83
+13.06%
|
1.62
-69.07%
|
5.25
+385.83%
|
1.08
|
| Hedging Assets Current |
|
1.16
-56.79%
|
2.69
+119.51%
|
1.23
-54.98%
|
2.72
|
| Other Current Assets |
|
18.07
+47.22%
|
12.27
-15.00%
|
14.44
+13.17%
|
12.76
|
| Total Non Current Assets |
|
2,649.78
+4.09%
|
2,545.61
-1.07%
|
2,573.18
+4.06%
|
2,472.70
|
| Net PPE |
|
1,163.96
+9.35%
|
1,064.44
+9.63%
|
970.95
+21.22%
|
801.01
|
| Gross PPE |
|
1,835.82
+12.84%
|
1,626.86
+10.24%
|
1,475.73
+19.02%
|
1,239.90
|
| Accumulated Depreciation |
|
-671.86
-19.46%
|
-562.41
-11.42%
|
-504.78
-15.01%
|
-438.90
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Land And Improvements |
|
470.90
+12.65%
|
418.04
+21.06%
|
345.31
+8.61%
|
317.93
|
| Machinery Furniture Equipment |
|
935.36
+13.31%
|
825.45
+7.18%
|
770.19
+22.21%
|
630.21
|
| Construction In Progress |
|
259.92
+3.79%
|
250.42
+1.38%
|
247.02
+27.57%
|
193.64
|
| Other Properties |
|
41.32
+18.33%
|
34.92
+14.01%
|
30.63
-0.35%
|
30.74
|
| Leases |
|
128.31
+30.89%
|
98.03
+18.70%
|
82.58
+22.55%
|
67.39
|
| Goodwill And Other Intangible Assets |
|
1,391.46
-0.52%
|
1,398.73
-8.43%
|
1,527.51
-4.11%
|
1,593.03
|
| Goodwill |
|
1,103.23
+2.05%
|
1,081.07
-2.71%
|
1,111.19
+0.86%
|
1,101.77
|
| Other Intangible Assets |
|
288.23
-9.26%
|
317.65
-23.70%
|
416.32
-15.26%
|
491.26
|
| Investments And Advances |
|
—
|
—
|
—
|
0.00
|
| Long Term Equity Investment |
|
—
|
—
|
—
|
0.00
|
| Non Current Deferred Assets |
|
3.85
+34.49%
|
2.87
-42.62%
|
4.99
+21.75%
|
4.10
|
| Non Current Deferred Taxes Assets |
|
3.85
+34.49%
|
2.87
-42.62%
|
4.99
+21.75%
|
4.10
|
| Other Non Current Assets |
|
36.69
-0.97%
|
37.05
-10.16%
|
41.24
+5.79%
|
38.98
|
| Total Liabilities Net Minority Interest |
|
2,657.16
-0.36%
|
2,666.74
-0.74%
|
2,686.69
-2.92%
|
2,767.47
|
| Current Liabilities |
|
249.58
+30.67%
|
191.00
-17.19%
|
230.65
-70.86%
|
791.57
|
| Payables And Accrued Expenses |
|
128.98
+15.15%
|
112.00
-30.32%
|
160.73
-69.67%
|
529.92
|
| Payables |
|
86.94
+30.58%
|
66.58
-14.20%
|
77.60
-6.03%
|
82.57
|
| Accounts Payable |
|
77.96
+41.50%
|
55.10
-22.44%
|
71.04
-4.18%
|
74.14
|
| Current Accrued Expenses |
|
42.03
-7.46%
|
45.42
-45.36%
|
83.13
-81.42%
|
447.34
|
| Employee Benefits |
|
8.12
+3.31%
|
7.86
-6.83%
|
8.44
+6.69%
|
7.91
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
43.54
+17.63%
|
37.02
+5.65%
|
35.04
+6.38%
|
32.94
|
| Total Tax Payable |
|
8.98
-21.79%
|
11.48
+75.11%
|
6.56
-22.26%
|
8.43
|
| Income Tax Payable |
|
5.69
-24.69%
|
7.56
+82.14%
|
4.15
-29.27%
|
5.87
|
| Current Debt And Capital Lease Obligation |
|
23.19
+1.80%
|
22.78
+16.82%
|
19.50
-90.55%
|
206.40
|
| Current Debt |
|
13.97
-5.61%
|
14.80
+208.59%
|
4.80
-97.57%
|
197.12
|
| Other Current Borrowings |
|
13.97
-5.61%
|
14.80
+208.59%
|
4.80
-97.57%
|
197.12
|
| Current Capital Lease Obligation |
|
9.22
+15.55%
|
7.98
-45.74%
|
14.71
+58.53%
|
9.28
|
| Current Deferred Liabilities |
|
18.00
+19.20%
|
15.10
+11.92%
|
13.49
+11.14%
|
12.14
|
| Current Deferred Revenue |
|
18.00
+19.20%
|
15.10
+11.92%
|
13.49
+11.14%
|
12.14
|
| Other Current Liabilities |
|
1.87
-54.32%
|
4.10
+889.86%
|
0.41
-88.20%
|
3.51
|
| Total Non Current Liabilities Net Minority Interest |
|
2,407.57
-2.75%
|
2,475.74
+0.80%
|
2,456.03
+24.30%
|
1,975.90
|
| Long Term Debt And Capital Lease Obligation |
|
2,250.46
-3.32%
|
2,327.85
+0.88%
|
2,307.55
+26.40%
|
1,825.65
|
| Long Term Debt |
|
2,126.72
-3.69%
|
2,208.10
-0.70%
|
2,223.67
+27.28%
|
1,747.12
|
| Long Term Capital Lease Obligation |
|
123.74
+3.33%
|
119.75
+42.76%
|
83.88
+6.81%
|
78.53
|
| Long Term Provisions |
|
53.50
+8.47%
|
49.32
+2.87%
|
47.94
+12.58%
|
42.59
|
| Defined Pension Benefit |
|
53.82
+26.56%
|
42.52
+49.30%
|
28.48
-19.93%
|
35.57
|
| Non Current Pension And Other Postretirement Benefit Plans |
|
8.12
+3.31%
|
7.86
-6.83%
|
8.44
+6.69%
|
7.91
|
| Non Current Deferred Liabilities |
|
88.13
+2.14%
|
86.28
+3.69%
|
83.22
-4.27%
|
86.93
|
| Non Current Deferred Revenue |
|
17.06
+1.63%
|
16.78
-10.54%
|
18.76
-0.74%
|
18.90
|
| Non Current Deferred Taxes Liabilities |
|
71.08
+2.27%
|
69.50
+7.83%
|
64.45
-5.25%
|
68.02
|
| Other Non Current Liabilities |
|
7.36
+66.59%
|
4.42
-50.24%
|
8.88
-30.80%
|
12.83
|
| Preferred Securities Outside Stock Equity |
|
—
|
—
|
—
|
—
|
| Stockholders Equity |
|
606.03
+49.67%
|
404.91
-8.75%
|
443.73
+26.69%
|
350.24
|
| Common Stock Equity |
|
606.03
+49.67%
|
404.91
-8.75%
|
443.73
+26.69%
|
350.24
|
| Capital Stock |
|
2.86
+0.00%
|
2.86
+0.00%
|
2.86
+0.00%
|
2.86
|
| Common Stock |
|
2.86
+0.00%
|
2.86
+0.00%
|
2.86
+0.00%
|
2.86
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
286.04
+0.00%
|
286.04
+0.00%
|
286.04
+0.00%
|
286.04
|
| Ordinary Shares Number |
|
284.37
+0.32%
|
283.47
+0.22%
|
282.83
+0.14%
|
282.42
|
| Treasury Shares Number |
|
1.67
-35.20%
|
2.57
-19.83%
|
3.21
-11.31%
|
3.62
|
| Additional Paid In Capital |
|
1,262.12
+1.47%
|
1,243.78
+2.35%
|
1,215.18
+2.15%
|
1,189.62
|
| Retained Earnings |
|
-532.09
+12.78%
|
-610.04
+6.78%
|
-654.44
+7.28%
|
-705.82
|
| Gains Losses Not Affecting Retained Earnings |
|
-109.84
+47.26%
|
-208.25
-124.69%
|
-92.68
+13.10%
|
-106.65
|
| Treasury Stock |
|
17.01
-27.40%
|
23.43
-13.79%
|
27.18
-8.71%
|
29.77
|
| Minority Interest |
|
—
|
—
|
0.00
|
0.00
|
| Other Equity Adjustments |
|
-109.84
+47.26%
|
-208.25
-124.69%
|
-92.68
+13.10%
|
-106.65
|
| Total Equity Gross Minority Interest |
|
606.03
+49.67%
|
404.91
-8.75%
|
443.73
+26.69%
|
350.24
|
| Total Capitalization |
|
2,732.76
+4.58%
|
2,613.01
-2.04%
|
2,667.41
+27.18%
|
2,097.35
|
| Working Capital |
|
363.83
+8.59%
|
335.04
+2.59%
|
326.59
+322.84%
|
-146.56
|
| Invested Capital |
|
2,746.73
+4.53%
|
2,627.81
-1.66%
|
2,672.20
+16.46%
|
2,294.47
|
| Total Debt |
|
2,273.65
-3.27%
|
2,350.63
+1.01%
|
2,327.06
+14.52%
|
2,032.04
|
| Net Debt |
|
1,796.08
-7.69%
|
1,945.66
+0.70%
|
1,932.06
+24.73%
|
1,549.02
|
| Capital Lease Obligations |
|
132.96
+4.09%
|
127.73
+29.56%
|
98.58
+12.27%
|
87.81
|
| Net Tangible Assets |
|
-785.42
+20.97%
|
-993.82
+8.30%
|
-1,083.77
+12.80%
|
-1,242.80
|
| Tangible Book Value |
|
-785.42
+20.97%
|
-993.82
+8.30%
|
-1,083.77
+12.80%
|
-1,242.80
|
| Current Provisions |
|
34.00
|
—
|
1.48
-77.82%
|
6.67
|
| Interest Payable |
|
20.54
-18.87%
|
25.32
-5.10%
|
26.68
+14.55%
|
23.29
|
| Inventories Adjustments Allowances |
|
-0.25
-15.60%
|
-0.22
+7.63%
|
-0.24
-101.71%
|
-0.12
|
| Investments In Other Ventures Under Equity Method |
|
—
|
—
|
—
|
0.00
|
| Investmentsin Associatesat Cost |
|
—
|
—
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
287.19
+28.12%
|
224.16
+251.74%
|
-147.73
-153.15%
|
277.96
|
| Cash Flow From Continuing Operating Activities |
|
287.19
+28.12%
|
224.16
+251.74%
|
-147.73
-153.15%
|
277.96
|
| Net Income From Continuing Operations |
|
77.95
+75.57%
|
44.40
-13.58%
|
51.38
+122.00%
|
-233.57
|
| Depreciation Amortization Depletion |
|
136.71
-16.46%
|
163.64
+3.62%
|
157.93
+8.50%
|
145.55
|
| Depreciation |
|
94.91
+12.64%
|
84.26
+10.03%
|
76.58
+19.65%
|
64.00
|
| Amortization Cash Flow |
|
41.80
-47.34%
|
79.38
-2.42%
|
81.35
-0.25%
|
81.55
|
| Depreciation And Amortization |
|
136.71
-16.46%
|
163.64
+3.62%
|
157.93
+8.50%
|
145.55
|
| Amortization Of Intangibles |
|
41.80
-47.34%
|
79.38
-2.42%
|
81.35
-0.25%
|
81.55
|
| Other Non Cash Items |
|
4.94
-82.77%
|
28.68
+366.67%
|
6.14
+593.57%
|
0.89
|
| Stock Based Compensation |
|
30.88
-16.04%
|
36.78
+14.08%
|
32.24
+51.99%
|
21.21
|
| Asset Impairment Charge |
|
—
|
0.00
|
0.00
-100.00%
|
9.61
|
| Deferred Tax |
|
0.02
-99.77%
|
9.43
+173.50%
|
3.45
+104.66%
|
-73.96
|
| Deferred Income Tax |
|
0.02
-99.77%
|
9.43
+173.50%
|
3.45
+104.66%
|
-73.96
|
| Operating Gains Losses |
|
8.65
+153.67%
|
-16.12
-464.80%
|
4.42
+538.93%
|
-1.01
|
| Gain Loss On Investment Securities |
|
-0.86
-139.00%
|
2.21
+235.19%
|
-1.64
-154.99%
|
2.98
|
| Net Foreign Currency Exchange Gain Loss |
|
9.52
+151.90%
|
-18.34
-402.74%
|
6.06
+252.03%
|
-3.98
|
| Change In Working Capital |
|
28.04
+165.78%
|
-42.63
+89.43%
|
-403.29
-198.55%
|
409.23
|
| Change In Receivables |
|
7.15
+222.70%
|
2.22
+110.20%
|
-21.72
-73.03%
|
-12.55
|
| Changes In Account Receivables |
|
7.15
+222.70%
|
2.22
+110.20%
|
-21.72
-73.03%
|
-12.55
|
| Change In Inventory |
|
-2.38
+49.99%
|
-4.75
+52.34%
|
-9.97
-169.05%
|
14.44
|
| Change In Payables And Accrued Expense |
|
7.13
+1416.17%
|
0.47
+125.64%
|
-1.83
-108.45%
|
21.70
|
| Change In Accrued Expense |
|
1.94
-72.72%
|
7.11
+103.26%
|
3.50
-83.01%
|
20.59
|
| Change In Payable |
|
5.18
+178.04%
|
-6.64
-24.58%
|
-5.33
-581.75%
|
1.11
|
| Change In Account Payable |
|
5.18
+178.04%
|
-6.64
-24.58%
|
-5.33
-581.75%
|
1.11
|
| Change In Other Working Capital |
|
28.54
+185.11%
|
-33.53
+90.98%
|
-371.79
-193.96%
|
395.67
|
| Change In Other Current Assets |
|
-12.69
-291.18%
|
-3.24
-186.16%
|
3.77
+136.18%
|
-10.40
|
| Change In Other Current Liabilities |
|
0.29
+107.78%
|
-3.79
-118.87%
|
-1.73
-552.48%
|
0.38
|
| Investing Cash Flow |
|
-135.14
+24.50%
|
-179.00
+16.71%
|
-214.91
-18.15%
|
-181.90
|
| Cash Flow From Continuing Investing Activities |
|
-135.14
+24.50%
|
-179.00
+16.71%
|
-214.91
-18.15%
|
-181.90
|
| Net PPE Purchase And Sale |
|
-138.02
+22.93%
|
-179.07
+16.70%
|
-214.97
-17.87%
|
-182.38
|
| Purchase Of PPE |
|
-138.02
+22.93%
|
-179.07
+16.70%
|
-214.97
-17.87%
|
-182.38
|
| Capital Expenditure |
|
-138.02
+22.93%
|
-179.07
+16.70%
|
-214.97
-17.87%
|
-182.38
|
| Net Business Purchase And Sale |
|
—
|
0.00
|
0.00
-100.00%
|
0.45
|
| Purchase Of Business |
|
—
|
—
|
0.00
|
0.00
|
| Net Other Investing Changes |
|
2.87
+3783.78%
|
0.07
+7.25%
|
0.07
+115.63%
|
0.03
|
| Financing Cash Flow |
|
-100.53
-98.83%
|
-50.56
-119.01%
|
265.96
+34.49%
|
197.76
|
| Cash Flow From Continuing Financing Activities |
|
-100.53
-98.83%
|
-50.56
-119.01%
|
265.96
+34.49%
|
197.76
|
| Net Issuance Payments Of Debt |
|
-86.10
-632.24%
|
-11.76
-103.95%
|
297.50
+48.75%
|
200.00
|
| Issuance Of Debt |
|
0.00
-100.00%
|
2,259.35
+351.87%
|
500.00
+150.00%
|
200.00
|
| Repayment Of Debt |
|
-86.10
+96.21%
|
-2,271.11
-1021.54%
|
-202.50
|
0.00
|
| Long Term Debt Issuance |
|
0.00
-100.00%
|
2,259.35
+351.87%
|
500.00
+150.00%
|
200.00
|
| Long Term Debt Payments |
|
0.00
+100.00%
|
-6.74
|
0.00
|
0.00
|
| Net Long Term Debt Issuance |
|
0.00
-100.00%
|
2,252.61
+350.52%
|
500.00
+150.00%
|
200.00
|
| Short Term Debt Issuance |
|
—
|
—
|
—
|
200.00
|
| Short Term Debt Payments |
|
-86.10
+96.20%
|
-2,264.37
-1018.21%
|
-202.50
|
0.00
|
| Net Short Term Debt Issuance |
|
-86.10
+96.20%
|
-2,264.37
-1018.21%
|
-202.50
|
0.00
|
| Net Common Stock Issuance |
|
—
|
-4.43
-8.29%
|
-4.09
|
0.00
|
| Common Stock Payments |
|
—
|
-4.43
-8.29%
|
-4.09
|
0.00
|
| Cash Dividends Paid |
|
—
|
—
|
—
|
—
|
| Repurchase Of Capital Stock |
|
—
|
-4.43
-8.29%
|
-4.09
|
0.00
|
| Proceeds From Stock Option Exercised |
|
-6.57
-48.33%
|
-4.43
-8.29%
|
-4.09
-940.46%
|
-0.39
|
| Net Other Financing Charges |
|
-7.86
+77.13%
|
-34.38
-25.23%
|
-27.45
-1387.11%
|
-1.85
|
| Changes In Cash |
|
51.52
+1054.73%
|
-5.40
+94.42%
|
-96.68
-132.90%
|
293.83
|
| Effect Of Exchange Rate Changes |
|
16.07
+192.42%
|
-17.39
-953.02%
|
2.04
+145.76%
|
-4.46
|
| Beginning Cash Position |
|
278.87
-7.55%
|
301.65
-23.88%
|
396.29
+270.63%
|
106.92
|
| End Cash Position |
|
346.46
+24.24%
|
278.87
-7.55%
|
301.65
-23.88%
|
396.29
|
| Free Cash Flow |
|
149.18
+230.81%
|
45.09
+112.43%
|
-362.71
-479.47%
|
95.58
|
| Interest Paid Supplemental Data |
|
164.01
-8.84%
|
179.92
+3.50%
|
173.84
+129.19%
|
75.85
|
| Income Tax Paid Supplemental Data |
|
60.87
-7.53%
|
65.83
+31.11%
|
50.21
-33.49%
|
75.50
|
| Common Stock Issuance |
|
—
|
—
|
—
|
0.00
|
| Issuance Of Capital Stock |
|
—
|
—
|
—
|
0.00
|
| Sale Of Business |
|
—
|
0.00
|
0.00
-100.00%
|
0.45
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-02 View
- 8-K2026-03-16 View
- 42026-03-10 View
- 42026-03-10 View
- 42026-03-10 View
- 8-K2026-03-06 View
- 42026-03-04 View
- 42026-03-04 View
- 42026-03-04 View
- 42026-03-04 View
- 10-K2026-02-24 View
- 8-K2026-02-24 View
- 42026-02-13 View
- 8-K2026-02-05 View
- 8-K2026-01-12 View
- 42025-12-10 View
- 42025-12-05 View
- 42025-12-05 View
- 42025-12-05 View
- 42025-11-12 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|